NWU22-12-01
OPEN TO ACCRUAL
PH2 Placebo-Controlled Trial of Urolithin a in Prostate Cancer Undergoing Radical Prostatectomy
S2312
OPEN TO ACCRUAL
Phase III Study of Cabazitaxel w/ or w/o Carboplatin in MCRPC Patients
UW22067
OPEN TO ACCRUAL
PET/CT Characterization of Treatment Resistance of AR-targeted therapies in mCRPC
UW24138
OPEN TO ACCRUAL
P3: Xaluritamig vs Cabazitaxel or 2nd Androgen Receptor-Directed Therapy w/progressive mCRPC